Findings from two case-control studies showed no significant difference in PTH levels between groups of patients with Alzheimer’s disease, other dementias, cognitive impairment and controls [39], or between patients with Alzheimer’s disease and a mixed control group with other type of dementia or a psychiatric illness [40]. The gene discussed is PTH; the disease is early-onset autosomal dominant Alzheimer disease.